1	Oct2	oct2	_	_	_	_	_	_	_
2	transactivation	transactivation	_	_	_	_	_	_	_
3	from	from	_	_	_	_	_	_	_
4	a	a	_	_	_	_	_	_	_
5	remote	remote	_	_	_	_	_	_	_
6	enhancer	enhancer	_	_	_	_	_	_	_
7	position	position	_	_	_	_	_	_	_
8	requires	require	_	_	_	_	_	_	_
9	a	a	_	_	_	_	_	_	_
10	B-cell-restricted	b-cell-restricted	_	_	_	_	_	_	_
11	activity	activity	_	_	_	_	_	_	_
12	.	.	_	_	_	_	_	_	_

1	Previous	previous	_	_	_	_	_	_	_
2	cotransfection	cotransfection	_	_	_	_	_	_	_
3	experiments	experiment	_	_	_	_	_	_	_
4	had	have	_	_	_	_	_	_	_
5	demonstrated	demonstrate	_	_	_	_	_	_	_
6	that	that	_	_	_	_	_	_	_
7	ectopic	ectopic	_	_	_	_	_	_	_
8	expression	expression	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	lymphocyte-specific	lymphocyte-specific	_	_	_	_	_	_	_
12	transcription	transcription	_	_	_	_	_	_	_
13	factor	factor	_	_	_	_	_	_	_
14	Oct2	oct2	_	_	_	_	_	_	_
15	could	could	_	_	_	_	_	_	_
16	efficiently	efficiently	_	_	_	_	_	_	_
17	activate	activate	_	_	_	_	_	_	_
18	a	a	_	_	_	_	_	_	_
19	promoter	promoter	_	_	_	_	_	_	_
20	containing	contain	_	_	_	_	_	_	_
21	an	an	_	_	_	_	_	_	_
22	octamer	octamer	_	_	_	_	_	_	_
23	motif	motif	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	Oct2	oct2	_	_	_	_	_	_	_
2	expression	expression	_	_	_	_	_	_	_
3	was	be	_	_	_	_	_	_	_
4	unable	unable	_	_	_	_	_	_	_
5	to	to	_	_	_	_	_	_	_
6	stimulate	stimulate	_	_	_	_	_	_	_
7	a	a	_	_	_	_	_	_	_
8	multimerized	multimerized	_	_	_	_	_	_	_
9	octamer	octamer	_	_	_	_	_	_	_
10	enhancer	enhancer	_	_	_	_	_	_	_
11	element	element	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	HeLa	HeLa	_	_	_	_	_	_	_
14	cells	cell	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	however	however	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	have	have	_	_	_	_	_	_	_
3	tested	test	_	_	_	_	_	_	_
4	a	a	_	_	_	_	_	_	_
5	variety	variety	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	Oct2	oct2	_	_	_	_	_	_	_
8	isoforms	isoform	_	_	_	_	_	_	_
9	generated	generate	_	_	_	_	_	_	_
10	by	by	_	_	_	_	_	_	_
11	alternative	alternative	_	_	_	_	_	_	_
12	splicing	splicing	_	_	_	_	_	_	_
13	for	for	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	capability	capability	_	_	_	_	_	_	_
16	to	to	_	_	_	_	_	_	_
17	activate	activate	_	_	_	_	_	_	_
18	an	an	_	_	_	_	_	_	_
19	octamer	octamer	_	_	_	_	_	_	_
20	enhancer	enhancer	_	_	_	_	_	_	_
21	in	in	_	_	_	_	_	_	_
22	nonlymphoid	nonlymphoid	_	_	_	_	_	_	_
23	cells	cell	_	_	_	_	_	_	_
24	and	and	_	_	_	_	_	_	_
25	a	a	_	_	_	_	_	_	_
26	B-cell	b-cell	_	_	_	_	_	_	_
27	line	line	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	Our	our	_	_	_	_	_	_	_
2	analyses	analysis	_	_	_	_	_	_	_
3	show	show	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	several	several	_	_	_	_	_	_	_
6	Oct2	oct2	_	_	_	_	_	_	_
7	isoforms	isoform	_	_	_	_	_	_	_
8	can	can	_	_	_	_	_	_	_
9	stimulate	stimulate	_	_	_	_	_	_	_
10	from	from	_	_	_	_	_	_	_
11	a	a	_	_	_	_	_	_	_
12	remote	remote	_	_	_	_	_	_	_
13	position	position	_	_	_	_	_	_	_
14	but	but	_	_	_	_	_	_	_
15	that	that	_	_	_	_	_	_	_
16	this	this	_	_	_	_	_	_	_
17	stimulation	stimulation	_	_	_	_	_	_	_
18	is	be	_	_	_	_	_	_	_
19	restricted	restricted	_	_	_	_	_	_	_
20	to	to	_	_	_	_	_	_	_
21	B	B	_	_	_	_	_	_	_
22	cells	cell	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	result	result	_	_	_	_	_	_	_
3	indicates	indicate	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	involvement	involvement	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	either	either	_	_	_	_	_	_	_
8	a	a	_	_	_	_	_	_	_
9	B-cell-specific	b-cell-specific	_	_	_	_	_	_	_
10	cofactor	cofactor	_	_	_	_	_	_	_
11	or	or	_	_	_	_	_	_	_
12	a	a	_	_	_	_	_	_	_
13	specific	specific	_	_	_	_	_	_	_
14	modification	modification	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	a	a	_	_	_	_	_	_	_
17	cofactor	cofactor	_	_	_	_	_	_	_
18	or	or	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	Oct2	oct2	_	_	_	_	_	_	_
21	protein	protein	_	_	_	_	_	_	_
22	in	in	_	_	_	_	_	_	_
23	Oct2-mediated	oct2-mediated	_	_	_	_	_	_	_
24	enhancer	enhancer	_	_	_	_	_	_	_
25	activation	activation	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	Mutational	mutational	_	_	_	_	_	_	_
2	analyses	analysis	_	_	_	_	_	_	_
3	indicate	indicate	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	carboxy-terminal	carboxy-terminal	_	_	_	_	_	_	_
7	domain	domain	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	Oct2	oct2	_	_	_	_	_	_	_
10	is	be	_	_	_	_	_	_	_
11	critical	critical	_	_	_	_	_	_	_
12	for	for	_	_	_	_	_	_	_
13	enhancer	enhancer	_	_	_	_	_	_	_
14	activation	activation	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	Moreover	moreover	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	this	this	_	_	_	_	_	_	_
4	domain	domain	_	_	_	_	_	_	_
5	conferred	confer	_	_	_	_	_	_	_
6	enhancing	enhancing	_	_	_	_	_	_	_
7	activity	activity	_	_	_	_	_	_	_
8	when	when	_	_	_	_	_	_	_
9	fused	fuse	_	_	_	_	_	_	_
10	to	to	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	Oct1	oct1	_	_	_	_	_	_	_
13	protein	protein	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	which	which	_	_	_	_	_	_	_
16	by	by	_	_	_	_	_	_	_
17	itself	itself	_	_	_	_	_	_	_
18	was	be	_	_	_	_	_	_	_
19	unable	unable	_	_	_	_	_	_	_
20	to	to	_	_	_	_	_	_	_
21	stimulate	stimulate	_	_	_	_	_	_	_
22	from	from	_	_	_	_	_	_	_
23	a	a	_	_	_	_	_	_	_
24	remote	remote	_	_	_	_	_	_	_
25	position	position	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	glutamine-rich	glutamine-rich	_	_	_	_	_	_	_
3	activation	activation	_	_	_	_	_	_	_
4	domain	domain	_	_	_	_	_	_	_
5	present	present	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	amino-terminal	amino-terminal	_	_	_	_	_	_	_
9	portion	portion	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	Oct2	oct2	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	POU	POU	_	_	_	_	_	_	_
15	domain	domain	_	_	_	_	_	_	_
16	contribute	contribute	_	_	_	_	_	_	_
17	only	only	_	_	_	_	_	_	_
18	marginally	marginally	_	_	_	_	_	_	_
19	to	to	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	transactivation	transactivation	_	_	_	_	_	_	_
22	function	function	_	_	_	_	_	_	_
23	from	from	_	_	_	_	_	_	_
24	a	a	_	_	_	_	_	_	_
25	distal	distal	_	_	_	_	_	_	_
26	position	position	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

